![](/img/cover-not-exists.png)
Real-World Study of Adding Bevacizumab to Chemotherapy for Ovarian, Tubal, and Peritoneal Cancer as Front-Line or Relapse Therapy (ROBOT): 8-Year Experience
Wu, Pei-Ying, Cheng, Ya-Min, Shen, Meng-Ru, Chen, Yi-Chun, Huang, Yu-Fang, Chou, Cheng-YangVolume:
10
Journal:
Frontiers in Oncology
DOI:
10.3389/fonc.2020.01095
Date:
July, 2020
File:
PDF, 880 KB
2020